The present invention describes novel dried powders of peptide therapeutic agent useful for producing highly respirable aerosols and the methods for their manufacture. Insulin is the peptide therapeutic agent in the preferred embodiment. The powders of insulin prepared for pulmonary administration are characterized by the peculiar structure and shape of the microparticles that allow the powder to flow and to be easy aerosolized. Typical dry powder of insulin described in this patent show corrugated, non-agglomerated microparticles with a low tapped density. The mean geometric diameter (particle size) ranges between 1.0 and 10.0 micron and the mass median aerodynamic diameter (MMAD) ranges between 1.0 and 4.0 micron. These insulin pulmonary powders exhibit in vitro a very high respirable fraction (>75%). Licenza concessa alla ditta Lisapharma di Erba (CO) da parte dell'Università degli Studi di Parma
INSULIN HIGHLY RESPIRABLE MICROPARTICLES / Colombo, Paolo; Cagnani, Stefano; Ventura, P.. - (2004).
INSULIN HIGHLY RESPIRABLE MICROPARTICLES
COLOMBO, Paolo;CAGNANI, Stefano;
2004-01-01
Abstract
The present invention describes novel dried powders of peptide therapeutic agent useful for producing highly respirable aerosols and the methods for their manufacture. Insulin is the peptide therapeutic agent in the preferred embodiment. The powders of insulin prepared for pulmonary administration are characterized by the peculiar structure and shape of the microparticles that allow the powder to flow and to be easy aerosolized. Typical dry powder of insulin described in this patent show corrugated, non-agglomerated microparticles with a low tapped density. The mean geometric diameter (particle size) ranges between 1.0 and 10.0 micron and the mass median aerodynamic diameter (MMAD) ranges between 1.0 and 4.0 micron. These insulin pulmonary powders exhibit in vitro a very high respirable fraction (>75%). Licenza concessa alla ditta Lisapharma di Erba (CO) da parte dell'Università degli Studi di ParmaFile | Dimensione | Formato | |
---|---|---|---|
JP4792457B2.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
85.85 kB
Formato
Adobe PDF
|
85.85 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
EP1734938 Intention to grant in Europe.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
805.28 kB
Formato
Adobe PDF
|
805.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Product ID 1440674.doc
non disponibili
Tipologia:
Abstract
Licenza:
Creative commons
Dimensione
23.5 kB
Formato
Microsoft Word
|
23.5 kB | Microsoft Word | Visualizza/Apri Richiedi una copia |
US7625865B2.pdf
non disponibili
Tipologia:
Altro materiale allegato
Licenza:
Creative commons
Dimensione
576.16 kB
Formato
Adobe PDF
|
576.16 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.